Show simple item record

dc.contributor.authorCleary, A.
dc.contributor.authorWalsh, F.
dc.contributor.authorConnolly, H.
dc.contributor.authorHays, V.
dc.contributor.authorOluwole, B.
dc.contributor.authorMacken, E.
dc.contributor.authorDowling, Maura
dc.date.accessioned2018-12-14T12:16:39Z
dc.date.available2018-12-14T12:16:39Z
dc.date.issued2012-09-14
dc.identifier.citationCLEARY, A., WALSH, F., CONNOLLY, H., HAYS, V., OLUWOLE, B., MACKEN, E., & DOWLING, M. (2012). Monitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health service. Journal of Psychiatric and Mental Health Nursing, 19(5), 395-401. doi: doi:10.1111/j.1365-2850.2011.01807.xen_IE
dc.identifier.issn1365-2850
dc.identifier.urihttp://hdl.handle.net/10379/14709
dc.description.abstractThis audit reviewed current practice within a rural mental health service area on the monitoring and documentation of side effects of antipsychotic depot medication. A sample of 60 case files, care plans and prescriptions were audited, which is 31% of the total number of service users receiving depot injections in the mental health service region (n= 181). The sample audited had a range of diagnoses, including: schizophrenia, schizoaffective disorder, bipolar affective disorder, depression, alcoholic hallucinosis and autism. The audit results revealed that most service users had an annual documented medical review and a documented prescription. However, only five (8%) case notes examined had documentation recorded describing the condition of the injection site, and alternation of the injection site was recorded in only 28 (47%) case notes. No case notes examined had written consent to commence treatment recorded. In 57 (95%) of case notes, no documentation of recorded information on the depot and on side effects was given. The failure to monitor and record some blood tests was partly attributed to a lack of clarity regarding whose responsibility it was. A standardized checklist has been developed as a result of the audit and this will be introduced by all teams across the service.en_IE
dc.formatapplication/pdfen_IE
dc.language.isoenen_IE
dc.publisherWileyen_IE
dc.relation.ispartofJournal Of Psychiatric And Mental Health Nursingen
dc.subjectantipsychoticsen_IE
dc.subjectauditen_IE
dc.subjectdepoten_IE
dc.subjectmental healthen_IE
dc.subjectmetabolic syndromeen_IE
dc.subjectside effectsen_IE
dc.subjectSCHIZOPHRENIAen_IE
dc.subjectPEOPLEen_IE
dc.subjectAKATHISIAen_IE
dc.subjectCOMMUNITYen_IE
dc.subjectNURSESen_IE
dc.titleMonitoring and documentation of side effects from depot antipsychotic medication: an interdisciplinary audit of practice in a regional mental health serviceen_IE
dc.typeArticleen_IE
dc.date.updated2018-12-03T21:37:45Z
dc.identifier.doiDOI 10.1111/j.1365-2850.2011.01807.x
dc.local.publishedsourcehttps://doi.org/10.1111/j.1365-2850.2011.01807.xen_IE
dc.description.peer-reviewedpeer-reviewed
dc.internal.rssid2195446
dc.local.contactMaura Dowling, School Of Nursing And Midwifery, Room 415 Aras Moyola, Newcastle Road, Galway. 3833 Email: maura.dowling@nuigalway.ie
dc.local.copyrightcheckedYes
dc.local.versionPUBLISHED
nui.item.downloads170


Files in this item

Attribution-NonCommercial-NoDerivs 3.0 Ireland
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. Please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.

The following license files are associated with this item:

Thumbnail

This item appears in the following Collection(s)

Show simple item record